As the global economy mends, the 2021 growth of Peptide Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Peptide Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Peptide Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Peptide Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peptide Vaccine market, reaching US$ million by the year 2028. As for the Europe Peptide Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peptide Vaccine players cover Anergis, Antigen Express, Apitope Technology, and Artificial Cell Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax